2022 ESMO World Congress on Gastrointestinal Cancer

An immune-related gene expression profile to predict the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the phase II randomized AtezoTRIBE study.

https://www.annalsofoncology.org/article/S0923-7534(22)01124-3/fulltext